El-Gamil M - Search Results

1

Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression.

Huang J, Khong HT, Dudley ME, El-Gamil M, Li YF, Rosenberg SA, Robbins PF. Huang J, et al. J Immunother. 2005 May-Jun;28(3):258-67. doi: 10.1097/01.cji.0000158855.92792.7a. J Immunother. 2005. PMID: 15838383 Free PMC article.

2

Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patient with a durable complete regression following immunotherapy.

Rosenberg SA, Tong-On P, Li Y, Riley JP, El-Gamil M, Parkhurst MR, Robbins PF. Rosenberg SA, et al. J Immunol. 2002 Mar 1;168(5):2402-7. doi: 10.4049/jimmunol.168.5.2402. J Immunol. 2002. PMID: 11859131 Free PMC article.

3

Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design.

Zeng G, Li Y, El-Gamil M, Sidney J, Sette A, Wang RF, Rosenberg SA, Robbins PF. Zeng G, et al. Cancer Res. 2002 Jul 1;62(13):3630-5. Cancer Res. 2002. PMID: 12097265 Free PMC article.

4

Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.

Robbins PF, El-Gamil M, Li YF, Zeng G, Dudley M, Rosenberg SA. Robbins PF, et al. J Immunol. 2002 Nov 15;169(10):6036-47. doi: 10.4049/jimmunol.169.10.6036. J Immunol. 2002. PMID: 12421991 Free PMC article.

5

Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes.

Maccalli C, Li YF, El-Gamil M, Rosenberg SA, Robbins PF. Maccalli C, et al. Cancer Res. 2003 Oct 15;63(20):6735-43. Cancer Res. 2003. PMID: 14583468 Free PMC article.

6

T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product.

Huang J, El-Gamil M, Dudley ME, Li YF, Rosenberg SA, Robbins PF. Huang J, et al. J Immunol. 2004 May 15;172(10):6057-64. doi: 10.4049/jimmunol.172.10.6057. J Immunol. 2004. PMID: 15128789 Free PMC article.

7

Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy.

Robbins PF, Dudley ME, Wunderlich J, El-Gamil M, Li YF, Zhou J, Huang J, Powell DJ Jr, Rosenberg SA. Robbins PF, et al. J Immunol. 2004 Dec 15;173(12):7125-30. doi: 10.4049/jimmunol.173.12.7125. J Immunol. 2004. PMID: 15585832 Free PMC article. Clinical Trial.

8

Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.

Huang J, Kerstann KW, Ahmadzadeh M, Li YF, El-Gamil M, Rosenberg SA, Robbins PF. Huang J, et al. J Immunol. 2006 Jun 15;176(12):7726-35. doi: 10.4049/jimmunol.176.12.7726. J Immunol. 2006. PMID: 16751420 Free PMC article.

9

Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond.

Cohen CJ, Li YF, El-Gamil M, Robbins PF, Rosenberg SA, Morgan RA. Cohen CJ, et al. Cancer Res. 2007 Apr 15;67(8):3898-903. doi: 10.1158/0008-5472.CAN-06-3986. Cancer Res. 2007. PMID: 17440104 Free PMC article.

10

Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions.

Robbins PF, Li YF, El-Gamil M, Zhao Y, Wargo JA, Zheng Z, Xu H, Morgan RA, Feldman SA, Johnson LA, Bennett AD, Dunn SM, Mahon TM, Jakobsen BK, Rosenberg SA. Robbins PF, et al. J Immunol. 2008 May 1;180(9):6116-31. doi: 10.4049/jimmunol.180.9.6116. J Immunol. 2008. PMID: 18424733 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters